Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?

Avram Fraint,1 Padmaja Vittal,2 Cynthia Comella2 1Department of Neurological Sciences, 2Section of Movement Disorders, Rush University Medical Center, Chicago, IL, USA Introduction: Botulinum toxin (BoNT) is the treatment of choice for many neurologic movement disorders, including blepharospasm, h...

Full description

Bibliographic Details
Main Authors: Fraint A, Vittal P, Comella C
Format: Article
Language:English
Published: Dove Medical Press 2016-02-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Online Access:https://www.dovepress.com/considerations-on-patient-related-outcomes-with-the-use-of-botulinum-t-peer-reviewed-article-TCRM